Joint Ventures Reduce the Risk of Major Capital Investments
Harvard Business Review
APRIL 6, 2016
The latest nuclear reactor designs, promising higher safety, longer operating life, and lower operating costs, cost up to $25 billion after factoring in the huge budget overruns. Benefits and risks of co-opetition. Building a large-scale biopharmaceutical facility requires up to $500 million.
8 
Let's personalize your content